KSS
Kohl's Corporation
KSS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
RIVN
Rivian Automotive, Inc.
RIVN has a slight edge over KSS overall, supported by stronger valuation and stronger modeled upside.
KSS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
KSS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
KSS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $14.11 | -40% |
| Fair | 8.2x | $18.88 | -20% |
| Current | 10x | $23.50 | — |
| Expensive | 11x | $26.18 | +11% |
Historical ranges are pointers, not guarantees.
KSS's PE is in its expensive range at 10x.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
KSS Forward outlook
There aren't enough analyst estimates for KSS to show an outlook.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
KSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.31 | +25% |
| Q2 2026 | $2.38 | +118% |
| Q1 2026 | $2.38 | +143% |
| Q4 2025 | $1.72 | -23% |
| Q3 2025 | $1.85 | -27% |
| Q2 2025 | $1.09 | -56% |
| Q1 2025 | $0.98 | -66% |
| Q4 2024 | $2.22 | +$3.23 |
KSS has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
KSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | -0.9% |
| Q2 2026 | $3.2B | -2% |
| Q1 2026 | $5.2B | -4.2% |
| Q4 2025 | $3.6B | -3.6% |
| Q3 2025 | $3.5B | -5% |
| Q2 2025 | $3.2B | -4.4% |
| Q1 2025 | $5.4B | -9.4% |
| Q4 2024 | $3.7B | -8.5% |
KSS's revenue fell from its 2020 peak and has held roughly level since: $3.5B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.4 points |
| Q2 2026 | 1.4% | -0.4 points |
| Q1 2026 | 4.1% | +1.8 points |
| Q4 2025 | 2% | -0.6 points |
| Q3 2025 | 7.9% | +3.4 points |
| Q2 2025 | 1.9% | +0.6 points |
| Q1 2025 | 2.3% | -2.7 points |
| Q4 2024 | 2.6% | -1.2 points |
KSS has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over KSS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
KSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $490M | -3.5% |
| Q2 2026 | -$158M | +$44M |
| Q1 2026 | $686M | +38% |
| Q4 2025 | $16M | +$339M |
| Q3 2025 | $508M | +260% |
| Q2 2025 | -$202M | -$69M |
| Q1 2025 | $497M | -30% |
| Q4 2024 | -$323M | -$317M |
KSS has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
KSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.4% | +6M shares |
| 1 year | +3.5% | +4M shares |
| 3 years | +6.3% | +7M shares |
| 5 years | -24% | -38M shares |
| Available history | -25% | -39M shares |
KSS has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | $500M |
| Q3 2022 | — |
| Q2 2022 | $158M |
| Q1 2022 | $548M |
| Q4 2021 | $506M |
| Q3 2021 | $255M |
| Q2 2021 | $46M |
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
KSS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.0x | Healthy |
KSS's net debt is less than a year of its operating earnings (EBITDA), down from 1.1 years a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.0 | Neutral |
| Stochastic | 80.9 | Overbought |
KSS's weekly RSI is 64 (neutral) and its Stochastic is 81 (overbought).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
KSS PE vs Consumer Cyclical Sector
| Metric | KSS | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 18x | 44% below |
| PE % | 75 | 47 | 28 pts above |
KSS is trading at 10x earnings, a 44% discount to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
KSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.8 | 8% above |
| 20 week MA | $19.5 | 20% above |
| 50 week MA | $18.0 | 31% above |
| 100 week MA | $15.0 | 57% above |
| 200 week MA | $19.2 | 22% above |
KSS has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
KSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.9 | $38.9 | -24% |
| 2021 | $38.9 | $50.2 | +29% |
| 2022 | $50.2 | $25.0 | -50% |
| 2023 | $25.0 | $28.7 | +15% |
| 2024 | $28.7 | $14.4 | -50% |
| 2025 | $14.4 | $21.6 | +50% |
| 2026 YTD | $21.6 | $23.5 | +8.9% |
KSS has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.